Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
scFOS for Prevention of Pouchitis
NCT02203955Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2014
- Primary completion
- Dec 2017
- Modality
- Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of fructooligosaccharide in pouchitis (2 arms), sponsored by Mayo Clinic. Primary endpoint: Pouchitis Disease Activity Index at 1 year. Started Aug 2014; status: completed.
02
Drugs
fructooligosaccharide
03
Conditions
pouchitis
Beyond the preview
Go deeper on NCT02203955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203955.